Come up with a name for your new list and we'll add to it:
Lotus Tissue Repair raised a round of funding on June 30, 2011. Investors include
Third Rock Ventures.
Lotus Tissue Repair is developing its recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating wound healing. T…